Results 101 to 110 of about 1,489 (180)

Translation, Cultural Adaptation, and Content Validation of a Pleural Mesothelioma Questionnaire to Portuguese Context - A Key Tool for Epidemiological Surveillance. [PDF]

Port J Public Health
Santos C, Sacadura-Leite E, Feijó S, Dixe MDA, Astoul P, Sousa-Uva A.   +5 more
europepmc   +1 more source

Mesotelioma primario del pericardio

, 2011
Introducción: El mesotelioma primario de pericardio (MPP) es una neoplasia extremadamente rara, que se origina de las células mesoteliales del pericardio. Esta neoplasia tiene la capacidad de invadir estructuras adyacentes y de originar metástasis a distancia; sin embargo, por su localización, generalmente es mortal en forma precoz. Hasta el momento se
Díaz-Pérez, Julio, Quiroga, Lucero, Rangel, Carlos, Remolina, Anderson, Hurtado-Gómez, Gabriel   +4 more
openaire   +1 more source

Descripción de un mesotelioma abdominal en un canino

, 1992
A seven months female dog, doberman with peritoneal mesothelioma is described for the first time in Chile.Se describe el caso de un canino de 7 meses de edad con un mesotelioma abdominal. Se hace referencia al diagnóstico, pronóstico y tratamiento.
López D., Javier (MV), González R, Alfonso (MV), Pérez S., Rodrigo (MV)   +2 more
core  

Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade. [PDF]

Open Respir Arch
Garcia-Prieto F, Pardo SC, Ramírez MTR, Fernández AA.   +3 more
europepmc   +1 more source

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer. [PDF]

Int J Mol Sci, 2021
Alhebshi H, Tian K, Patnaik L, Taylor R, Bezecny P, Hall C, Muller PAJ, Safari N, Creamer DPM, Demonacos C, Mutti L, Bittar MN, Krstic-Demonacos M.   +12 more
europepmc   +1 more source

La reutilización de biomarcadores para otros fines: oportunidades y dificultades en el cambiante campo de la medicina de laboratorio. [PDF]

Adv Lab Med
Gruson D, Menghoun N, Pouleur AC, Bayes Genis A.   +3 more
europepmc   +1 more source

Malignant pleural mesothelioma: an update. [PDF]

J Bras Pneumol, 2021
Hajj GNM, Cavarson CH, Pinto CAL, Venturi G, Navarro JR, Lima VCC.   +5 more
europepmc   +1 more source

Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico. [PDF]

Ecancermedicalscience
Meraz-Brenez A, Soto-Perez-De-Celis E, Demichelis-Gomez R, Verduzco-Rodriguez L, Gupta A, Ragavan M, Chino F, Verduzco-Aguirre HC.   +7 more
europepmc   +1 more source

Comparison of mortality in patients on chemotherapy or immunotherapy during and before COVID-19 pandemic. Multicenter matched cohort study in Argentina. [PDF]

Rev Peru Med Exp Salud Publica, 2023
Itkin B, Straminsky S, Cáceres H, Onassis M, García AE, Avanzi L, Kaminszczik L, Serna Sejas R, Rapaccioli M, Billordo G, Lavaccara D, Lanzavecchia J, Gibbons L, Settecase E, Bardach A.   +14 more
europepmc   +1 more source

Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer. [PDF]

Mol Oncol
Rigon M, Mutti L, Campanella M.
europepmc   +1 more source